These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17292472)

  • 21. Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes.
    Bettahi I; Dasgupta G; Renaudet O; Chentoufi AA; Zhang X; Carpenter D; Yoon S; Dumy P; BenMohamed L
    Cancer Immunol Immunother; 2009 Feb; 58(2):187-200. PubMed ID: 18584174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
    Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
    Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo hierarchy of individual T-cell epitope-specific helper T-cell subset against an intracellular bacterium.
    Nagata T; Aoshi T; Uchijima M; Koide Y
    Vaccine; 2008 Sep; 26(40):5123-7. PubMed ID: 18450341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of linear and comb-like peptide constructs containing up to four copies of a T cell epitope and their capacity to stimulate T cells.
    Mack J; Falk K; Rötzschke O; Walk T; Strominger JL; Jung G
    J Pept Sci; 2001 Jun; 7(6):338-45. PubMed ID: 11461048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.
    Resende DM; Caetano BC; Dutra MS; Penido ML; Abrantes CF; Verly RM; Resende JM; Piló-Veloso D; Rezende SA; Bruna-Romero O; Fernandes AP; Gazzinelli RT
    Vaccine; 2008 Aug; 26(35):4585-93. PubMed ID: 18588933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers.
    Jackson DC; Fitzmaurice C; Sheppard RC; McMurray J; Brown LE
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):171-6. PubMed ID: 9346849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multispecific responses by T cells expanded by endogenous self-peptide/MHC complexes.
    Cai G; Hafler DA
    Eur J Immunol; 2007 Mar; 37(3):602-12. PubMed ID: 17304631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
    Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
    J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors.
    Mizukami S; Kajiwara C; Ishikawa H; Katayama I; Yui K; Udono H
    Cancer Sci; 2008 May; 99(5):1008-15. PubMed ID: 18341654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
    Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
    Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel T-cell epitopes of ovalbumin in BALB/c mouse: potential for peptide-immunotherapy.
    Yang M; Mine Y
    Biochem Biophys Res Commun; 2009 Jan; 378(2):203-8. PubMed ID: 19022223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity.
    Claassen EA; van Bleek GM; Rychnavska ZS; de Groot RJ; Hensen EJ; Tijhaar EJ; van Eden W; van der Most RG
    Virology; 2007 Nov; 368(1):17-25. PubMed ID: 17632195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.